(Q33203486)

English

Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma (English)

1 reference

Europe PubMed Central

23 July 2017

1 reference

based on heuristic

inferred from title

author name string

Ross Brown

1

1 reference

Europe PubMed Central

23 July 2017

Allan Murray

2

1 reference

Europe PubMed Central

23 July 2017

Belinda Pope

3

1 reference

Europe PubMed Central

23 July 2017

Daniel M Sze

4

1 reference

Europe PubMed Central

23 July 2017

John Gibson

5

1 reference

Europe PubMed Central

23 July 2017

P Joy Ho

6

1 reference

Europe PubMed Central

23 July 2017

Derek Hart

7

1 reference

Europe PubMed Central

23 July 2017

Doug Joshua

8

1 reference

Europe PubMed Central

23 July 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

23 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

23 July 2017

125

1 reference

Europe PubMed Central

23 July 2017

743-748

1 reference

Europe PubMed Central

23 July 2017

6

1 reference

Europe PubMed Central

23 July 2017

CMRF44+ dendritic cells from peripheral blood stem cell harvests of patients with myeloma as potential cellular vectors for idiotype vaccination.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: Harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04984.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.04984.X

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33203486&oldid=1790187353"